CompuGroup Medical SE & Co. KGaA

XTRA:COP Voorraadrapport

Marktkapitalisatie: €698.9m

CompuGroup Medical SE KGaA Beheer

Beheer criteriumcontroles 2/4

De CEO CompuGroup Medical SE KGaA is Daniel Gotthardt, benoemd in Sep2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 6.92% van de aandelen van het bedrijf, ter waarde € 48.35M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2 jaar en 3.8 jaar.

Belangrijke informatie

Daniel Gotthardt

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEO6.9%
Management gemiddelde ambtstermijn2yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital

Sep 06
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital

Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden

Aug 20
Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden

What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash

Aug 04
What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash

CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price

Jul 18
CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price

Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Jul 15
Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)

Jun 11
Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)

The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

May 24
The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20

May 11
Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20

CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00

Apr 27
CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00

CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's

Apr 12
CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's

We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Mar 20
We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate

Feb 08
CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate

Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings

Jan 25
Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings

Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Jan 12
Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?

The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

Dec 28
The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence

We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Dec 15
We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?

Oct 09
Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?

CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital

Sep 22
CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital

Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?

Sep 07
Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?

Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?

Aug 23
Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?

Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly

Jul 13
Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly

At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?

Jun 24
At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?

CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return

May 27
CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return

CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50

May 11
CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50

Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?

May 06
Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?

We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

Apr 06
We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt

What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?

Mar 07
What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?

Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital

Feb 06
Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital

An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued

Jan 21
An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued

These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well

Jan 05
These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well

Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?

Dec 06
Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?

CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital

Oct 27
CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital

Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?

Oct 12
Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?

At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?

Sep 04
At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?

CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet

Aug 04
CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet

Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital

Jul 16
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital

When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?

May 31
When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?

CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50

May 11
CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50

CEO

Daniel Gotthardt (51 yo)

less than a year

Tenure

€60,000

Compensatie

Dr. Daniel Gotthardt is MD & CEO of CompuGroup Medical SE & Co. KGaA since September 1, 2024 and had been its Chief Medical Officer since 2023 until September 2024 and was its Senior Vice President from 20...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Hannes Reichl
MD of Impatient & Social Care and Member of the Management Board6yrs€1.77m0.0077%
€ 54.0k
Emanuele Mugnani
MD of Ambulatory Information Systems Europe & Member of Management Board3yrs€690.00k0.0014%
€ 9.4k
Ulrich Thome
MD of Ambulatory Information Systems DACH & Member of the Management Boardless than a year€2.40m0.00057%
€ 4.0k
Daniel Gotthardt
MD & CEOless than a year€60.00k6.92%
€ 48.3m
Daniela Hommel
MD, CFO & Member of Management Boardless than a yeargeen gegevensgeen gegevens
Claudia Thomé
Corporate Vice President of Investor Relationsno datageen gegevensgeen gegevens
Helge Weiß
Senior Vice President of Connectivity4.8yrsgeen gegevensgeen gegevens

2.0yrs

Gemiddelde duur

50.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van COP wordt beschouwd als ervaren (gemiddelde ambtstermijn 2 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Philipp von Ilberg
Chairman of Supervisory Board4.4yrs€100.00kgeen gegevens
Dierk Heimann
Member of Medical Advisory Boardno datageen gegevensgeen gegevens
Ulrike Handel
Independent Member of Supervisory Board4.4yrs€48.00kgeen gegevens
Bettina Volkens
Member of Supervisory Board4.4yrs€40.00kgeen gegevens
Matthias Stormer
Member of Supervisory Board4.4yrs€60.00k0.0025%
€ 17.5k
Martin Kohrmann
Member of Supervisory Board4.4yrs€40.00k0.015%
€ 108.1k
Ayfer Basal
Employee Representative Member of Supervisory Board3.2yrs€50.00kgeen gegevens
Adelheid Hegemann
Employee Representative Member of Supervisory Board3.2yrs€40.00k0.000070%
€ 489.3
Frank Betz
Employee Representative Member of Supervisory Board3.2yrs€50.00kgeen gegevens
Stefan Weinmann
Vice Chairman of the Supervisory Board3.2yrs€60.00k0.000050%
€ 349.5
Julia Mole
Employee Representative Member of Supervisory Board3.8yrs€40.00kgeen gegevens
Reinhard Lyhs
Member of Supervisory Board1.7yrs€34.00k0.00039%
€ 2.7k

3.8yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van COP wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).